|
|
|
|
pmid:28958841
|
|
|
|
|
pmid:27663770
|
|
|
|
|
pmid:
|
Nithipatikom K et al. |
Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay. |
1997 |
Anal. Biochem. |
pmid:9073364
|
Fang X et al. |
Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. |
1997 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:9430380
|
Fang X et al. |
14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. |
1998 |
Am. J. Physiol. |
pmid:9843811
|
Oltman CL et al. |
Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. |
1998 |
Circ. Res. |
pmid:9797342
|
Weintraub NL et al. |
Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. |
1999 |
Am. J. Physiol. |
pmid:10564166
|
Tréluyer JM et al. |
Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome. |
2000 |
Pediatr. Res. |
pmid:10813596
|
Campbell WB et al. |
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:11959628
|
Oleksiak MF et al. |
Identification and regulation of a new vertebrate cytochrome P450 subfamily, the CYP2Ps, and functional characterization of CYP2P3, a conserved arachidonic acid epoxygenase/19-hydroxylase. |
2003 |
Arch. Biochem. Biophys. |
pmid:12623071
|
Widstrom RL et al. |
Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase. |
2003 |
Biochemistry |
pmid:14529287
|
Roy U et al. |
Cytochrome P450/NADPH-dependent formation of trans epoxides from trans-arachidonic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15013014
|
Spiecker M et al. |
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. |
2004 |
Circulation |
pmid:15466638
|
Nithipatikom K et al. |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. |
2004 |
Circ. Res. |
pmid:15388642
|
Fang X et al. |
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15284062
|
Krötz F et al. |
Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:14715644
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Fang X et al. |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16113065
|
Ng VY et al. |
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. |
2007 |
Drug Metab. Dispos. |
pmid:17431031
|